ZencirogluAKaragolBSIpekMSOkumusNYaraliNAydinM.Neonatal purpura fulminans secondary to group B Streptococcal infection. Pediatr Hematol Oncol. 2010;27:620-625.
3.
FitzgeraldCJPranikoffTVRossGAMouSGivnerLBShettyAK.Purpura fulminans caused by community-associated methicillin resistantStaphylococcus aureus. Am J Emerg Med. 2012;30:1013.e1-1013.e4.
4.
DarmstadtGL.Acute infectious purpura fulminans: pathogenesis and medical management. Pediatr Dermatol. 1998;15:169-183.
5.
SheridanRLBriggsSERemensnyderJPTompkinsRG.Management strategy in purpura fulminans with multiple organ failure in children. Burns. 1996;22:53-56.
6.
GürgeyAAytacSKanraGSecmeerGCeyhanMAltayC.Outcome in children with purpura fulminans: report on 16 patients. Am J Hematol. 2005;80:20-25.
7.
PriceVELedinghamDLKrümpelAChanAK.Diagnosis and management of neonatal purpura fulminans. Semin Fetal Neonatal Med. 2011;16:318-322.
8.
KravitzGRDriesDJPetersonMLSchlievertPM.Purpura fulminans due toStaphylococcus aureus. Clin Infect Dis. 2005;40:941-947.
9.
RosensteinNPerkinsB.Meningococcal disease. N Engl J Med. 2001;344:1378-1388.
10.
DhodapkarKCorbaciogluSChangMWKarpatkinMDiMicheleD.Purpura fulminans caused by group A beta-hemolytic Streptococcus sepsis. J Pediatr. 2000;137:562-567.
11.
NogueraAFortunyCPonsMCambraFPalomequeA.Pneumococcal-associated purpura fulminans in a healthy infant. Pediatr Emerg Care. 2004;20:528-530.
12.
HonKLSoKWWongWCheungKL.Spot diagnosis: an ominous rash in a newborn. Ital J Pediatr. 2009;35:10.
13.
VermaPPandhiDYadavPDhawanAK.Neonatal purpura fulminans due to methicillin resistantStaphylococcus aureus. Pediatr Dermatol. 2013;30:266-267.
14.
HussainARobinsonGMalkinJDuthieMKearnsAPereraN.Purpura fulminans in a child secondary to Panton-Valentine leucocidin–producing Staphylococcus aureus. J Med Microbiol. 2007;56(pt 10):1407-1409.
15.
MushtaqFHildrewSOkugbeniGEllisRWDeshpandeS.Necrotizing haemorrhagic pneumonia proves fatal in an immunocompetent child due to Panton-Valentine leucocidin, toxic shock syndrome toxins 1 and 2 and enterotoxin C–producing Staphylococcus aureus. Acta Paediatr. 2008;97:985-987.
16.
MacLarenGButtWBestDDonathSTaylorA.Extracorporeal membrane oxygenation for refractory septic shock in children: one institution’s experience. Pediatr Crit Care Med. 2007;8:447-451.
17.
BetrosianAPBerletTAgarwalB.Purpura fulminans in sepsis. Am J Med Sci. 2006;332:339-345.
18.
HarrisonOBRobertsonBDFaustSN. Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV Pili, and PorA by Neisseria meningitidis in vivo. Infect Immun. 2002;70:5193-5201.
19.
ChildersBJCobanovB.Acute infectious purpura fulminans: retrospective review of 28 cases. Am Surg. 2003;69:86-90.
20.
RichPBYoungerJSoldesOSAwadSSBartlettRH.The use of extracorporeal life support for adult patients with respiratory failure and sepsis. ASAIO J. 1998;44:263-266.
